Walleye Trading
DARE icon

Walleye Trading’s Dare Bioscience DARE Stock Holding History

Walleye Trading’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11
Closed -$1K – 4752
2016
Q4 		$1K Hold
11
– – ﹤0.01% 4593
2016
Q3 		$1K Buy
+11
New +$2.46K ﹤0.01% 4696
2015
Q4 		– Sell
-16
Closed -$7K – 5348
2015
Q3 		$7K Buy
+16
New +$8.04K ﹤0.01% 4504

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Trading's DARE Position: Q1 2017 in Review

Walleye Trading sold out of Dare Bioscience (DARE) in Q1 2017, closing a stake of 11 shares — an estimated $1K sold.

Walleye Trading first reported a position in DARE in Q3 2015 and held it in 3 quarters. The position peaked at $7K in Q3 2015. 27 funds tracked by Wall St. Rank hold DARE as of Q1 2017.

  • Walleye Trading reported no remaining Dare Bioscience position as of Q1 2017 after selling out during the quarter.
  • Walleye Trading sold 11 Dare Bioscience shares in Q1 2017, an estimated $1K.
  • Walleye Trading first reported a position in Dare Bioscience in Q3 2015 and held it in 3 quarters.
  • Walleye Trading's Dare Bioscience position peaked at $7K in Q3 2015.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2017.

Based on Walleye Trading's 13F filing for Q1 2017, filed 15 May 2017.